Agnes Malysa
4th Year 

Dissertation Mentor:  Gerold Bepler, MD/PhD

Research focus: Non-small cell lung cancer, biomarker discovery

Grants, Awards, Scholarships:
2019 - 2020 Cancer Biology Director's Award

Committee(s):

2019 Cancer Biology Graduate Program Curriculum Committee

Publications:

Patki, M., McFall, T., Rosati, R., Huang,Y., Malysa, A., Polin, L.,  Fielder, A., Wilson, M., Lonardo, F., Back, J., Li, J., Matherly, L.,  Bepler, G., &  Manohar, R. Chronic Induction of P27Kip1 by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Over-expressing Glucocorticoid Receptor. Clinical Cancer Research. 2018;8:16006.

Gibson H.M., McKnight B.N., Malysa A., Dyson G., Wiesend W., McCarthy C.E., Reyes J., Wei W.Z., Viola-Villegas,  N.T. Interferon-gamma PET Imaging as a Predictive Tool for monitoring response to tumor immunotherapy. Cancer Research. 2018;78:5706-17.

Chammaa, M., Malysa, A., Redondo, C., Jang, H., Chen, W., Bepler, G., & Fernandez-Valdivia, R. Rumi is a novel prognostic marker and therapeutic target in Non-Small Cell Lung Cancer. Journal of Cellular Physiology. 2018;233:9548-62.

Fridman, R., Huang, & P.H. Discoidin Domain Receptors in Health and Disease. Part II, Section 8. Discoid Domain receptors in Lung Cancer. Zhang, Y., Malysa, A., & Bepler, G.ISBN 978-1-4939-6381-2

Zhou, J, Li, X, Alosh, B, Malysa, A, Chen, W, Bepler, G, Rouba, AF. Excision Repair Cross Complementing Group 1 (ERCC1): An Independent Prognostic Marker for Endometrial and Ovarian Cancer. Translational Biomedicine. 2015. Special Issue: ISSN 2172-0479.

Vaezi, A., Bepler, G., Bhagwat, N., Malysa, A., Rubatt, JM., Chen, W., Hood, BL, Conrads, T., Wang, L., Kemp, C., & Niedernhofer, L.  Choline phosphate cytidylyltransferase-alpha is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer. 2014;120:1898-907

Zhou, J., Chen, Z., Malysa, A., Li, X., Oliveira, P., Zhang, Y., & Bepler, G. A Kinome screen identifies checkpoint kinase 1 (CHK1) as sensitizer for RRM1-dependent gemcitabine efficacy. PLoS One. 2013;8:e58091.

Al Sorkhy, M., Ferraiuolo, R.M., Jalili, E., Malysa, A., Fratiloiu, A.R., Sloane, B.F., & Porter, L.A. The Cyclin-like protein, Spy1/RINGO, is a novel mammary oncogene functioning through the G2/M kinase Cdk1. BMC Cancer. 12(45).

Education:

2008 - 2010 Master of Science - Biological Sciences, University of Windsor, Windsor, ON
2005 - 2006 Honours Bachelor of Science - Biological Sciences with Thesis, Biological Sciences, University of Windsor, Windsor, ON
2004 - 2005 Bachelor of Education - Intermediate/Senior, Biological Sciences, University of Windsor, Windsor, ON
2000 - 2004 Bachelor of Science - General Science, Biological Sciences, University of Windsor, Windsor, ON

Teaching Experience:

Teachable: Biology and Chemistry
2008 - 2010 Graduate Teaching Assistant - Biology Department, University of Windsor
2005 - 2006 Student Teacher for Grades 7-12, University of Windsor

Hometown: Windsor, ON, Canada